BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12217336)

  • 1. Anti-CD200R ameliorates collagen-induced arthritis in mice.
    Gorczynski RM; Chen Z; Lee L; Yu K; Hu J
    Clin Immunol; 2002 Sep; 104(3):256-64. PubMed ID: 12217336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD200 immunoadhesin suppresses collagen-induced arthritis in mice.
    Gorczynski RM; Chen Z; Yu K; Hu J
    Clin Immunol; 2001 Dec; 101(3):328-34. PubMed ID: 11726225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD200-Fc, a novel antiarthritic biologic agent that targets proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis.
    Simelyte E; Criado G; Essex D; Uger RA; Feldmann M; Williams RO
    Arthritis Rheum; 2008 Apr; 58(4):1038-43. PubMed ID: 18383359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CD200FC immunoadhesin prolongs rat islet xenograft survival in mice.
    Gorczynski RM; Hu J; Chen Z; Kai Y; Lei J
    Transplantation; 2002 Jun; 73(12):1948-53. PubMed ID: 12131694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor.
    Piguet PF; Grau GE; Vesin C; Loetscher H; Gentz R; Lesslauer W
    Immunology; 1992 Dec; 77(4):510-4. PubMed ID: 1337334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-12 promotes cellular but not humoral type II collagen-specific Th 1-type responses in C57BL/6 and B10.Q mice and fails to induce arthritis.
    Szeliga J; Hess H; Rüde E; Schmitt E; Germann T
    Int Immunol; 1996 Aug; 8(8):1221-7. PubMed ID: 8918691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the adjuvant effect of IL-12 and efficacy of IL-12 inhibitors in type II collagen-induced arthritis.
    Germann T; Hess H; Szeliga J; Rüde E
    Ann N Y Acad Sci; 1996 Oct; 795():227-40. PubMed ID: 8958934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with an anti-IL-4 monoclonal antibody blocks suppression of collagen-induced arthritis in mice by oral administration of type II collagen.
    Yoshino S
    J Immunol; 1998 Mar; 160(6):3067-71. PubMed ID: 9510213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis.
    Mauri C; Williams RO; Walmsley M; Feldmann M
    Eur J Immunol; 1996 Jul; 26(7):1511-8. PubMed ID: 8766554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy.
    Triantaphyllopoulos KA; Williams RO; Tailor H; Chernajovsky Y
    Arthritis Rheum; 1999 Jan; 42(1):90-9. PubMed ID: 9920019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent adjuvant effect by anti-CD40 in collagen-induced arthritis. Enhanced disease is accompanied by increased production of collagen type-II reactive IgG2a and IFN-gamma.
    Tellander AC; Michaëlsson E; Brunmark C; Andersson M
    J Autoimmun; 2000 Jun; 14(4):295-302. PubMed ID: 10882055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram.
    Ross SE; Williams RO; Mason LJ; Mauri C; Marinova-Mutafchieva L; Malfait AM; Maini RN; Feldmann M
    J Immunol; 1997 Dec; 159(12):6253-9. PubMed ID: 9550429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of lipopolysaccharide injected systemically in the reactivation of collagen-induced arthritis in mice.
    Yoshino S; Ohsawa M
    Br J Pharmacol; 2000 Apr; 129(7):1309-14. PubMed ID: 10742285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression of collagen-induced arthritis in mice with an anti-IL-2 receptor antibody.
    Banerjee S; Wei BY; Hillman K; Luthra HS; David CS
    J Immunol; 1988 Aug; 141(4):1150-4. PubMed ID: 3135321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-gamma.
    Cooper SM; Sriram S; Ranges GE
    J Immunol; 1988 Sep; 141(6):1958-62. PubMed ID: 3139747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistance.
    Foell JL; Diez-Mendiondo BI; Diez OH; Holzer U; Ruck P; Bapat AS; Hoffmann MK; Mittler RS; Dannecker GE
    Immunology; 2004 Sep; 113(1):89-98. PubMed ID: 15312139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4.
    Ranges GE; Sriram S; Cooper SM
    J Exp Med; 1985 Sep; 162(3):1105-10. PubMed ID: 3928802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen-induced arthritis in DBA/1 mice: cytokine gene activation following immunization with type II collagen.
    Stasiuk LM; Abehsira-Amar O; Fournier C
    Cell Immunol; 1996 Nov; 173(2):269-75. PubMed ID: 8912886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of gamma delta T cells in murine collagen-induced arthritis.
    Peterman GM; Spencer C; Sperling AI; Bluestone JA
    J Immunol; 1993 Dec; 151(11):6546-58. PubMed ID: 8245484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for the lymphotoxin/LIGHT axis in the pathogenesis of murine collagen-induced arthritis.
    Fava RA; Notidis E; Hunt J; Szanya V; Ratcliffe N; Ngam-Ek A; De Fougerolles AR; Sprague A; Browning JL
    J Immunol; 2003 Jul; 171(1):115-26. PubMed ID: 12816989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.